Increased QT variability in young asymptomatic patients with β-thalassemia major

European Journal of Haematology

Volumn 79, Issue 4, 2007, Pages 322-329

  Magrì, Damiano ^a,b   Sciomer, Susanna ^a   Fedele, Francesco ^a   Gualdi, Gianfranco ^a   Casciani, Emanuele ^a   Pugliese, Pellegrina ^a   Losardo, Anna ^a   Ferrazza, Giancarlo ^a   Pasquazzi, Eleonora ^a   Schifano, Erika ^a   Magnanti, Marzia ^a   Matera, Sabrina ^a   Marigliano, Vincenzo ^a   Piccirillo, Gianfranco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

thalassemia major; QT interval; QT variability; Sudden cardiac death

Indexed keywords

DEFERIPRONE; DEFEROXAMINE;

ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HUMAN; IRON CHELATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; QT INTERVAL; REPOLARIZATION; SUDDEN DEATH; SYMPTOMATOLOGY; THALASSEMIA; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IRON; MALE; MYOCARDIUM; RISK ADJUSTMENT;

EID: 34548583238     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00921.x     Document Type: Article

References (35)

1. Borna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complication in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004 89: 1187 93.
2. Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassemia major. Lancet 1989 2: 27 30.
3. Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y Acad Sci 2005 1054: 445 50.
4. Taher A, Sheikh-Taha M, Koussa S, Inati A, Neeman R, Mourad F. Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients. Eur J Hematol 2001 67: 30 4.
5. Borna-Pignatti C, Cappellini MD, De Stefano P, et al. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood 2006 107: 3733 7.
6. Pennell DJ, Berdoukas V, Karagiorga M, et al. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 2006 107: 3738 44.
7. Atiga WL, Calkins H, Lawrence JH, Tomaselli GF, Smith JM, Berger RD. Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol 1998 9: 899 908.
8. Piccirillo G, Magrì D, Matera S, et al. QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular dysfunction: a prospective study. Eur Heart J 2007 28(11): 1344 50.
9. Haigney MC, Zareba W, Gentlesk PJ, et al. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II. J Am Coll Cardiol 2004 44: 1481 7.
10. Ulger Z, Aydinok Y, Levent E, Gurses D, Ozyurek AR. Evaluation of QT dispersion in β-thalassemia major patients. Am J Hematol 2006 81: 901 6.
11. Zabel M, Klingenheden T, Franz MR, Honloser SH. Assessment of QT dispersion for predication of mortality or arrhythmic event after myocardial infarction: result of prospective, long-term follow up study. Circulation 1998 97: 2543 50.
12. Brendorp B, Elming H, Jun L, et al. QT dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function. Circulation 2001 103: 831 5.
13. Piccirillo G, Santagada E, Viola E, et al. Autonomic modulation of heart rate and blood pressure in hypertensive subjects with symptoms of anxiety. Clin Sci 1998 95: 43 52.
14. Piccirillo G, Viola E, Bucca C, et al. QT interval dispersion and autonomic modulation in subjects with anxiety. J Clin Lab Med 1999 133: 461 8.
15. Piccirillo G, Germanò G, Vitarelli A, et al. Autonomic cardiovascular control and diastolic dysfunction in hypertensive subjects. Int J Cardiol 2006 110: 160 6.
16. Sahan DJ, De Maria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: result of a survey of echocardiographic measurements. Circulation 1978 58: 1072 80.
17. De Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and the impact of overweight. J Am Coll Cardiol 1992 20: 1251 60.
18. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2 star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001 22: 2171 9.
19. Westwood M, Anderson LJ, Firmin D, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003 18: 33 9.
20. El-Omar M, Kardos A, Casadei B. Mechanism of respiratory sinus arrhythmia in patients with mild heart failure. Am J Physiol Heart Circ Physiol 2001 280: H215 31.
21. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability. Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997 96: 1557 65.
22. Bazett HC. An analysis of the time relations of electrocardiograms. Heart 1920 7: 353 70.
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986 8: 307 10.
24. Piccirillo G, Quaglione R, Nocco M, et al. Effects of long-term β-blocker therapy on QT variability index in subjects with chronic heart failure. Am J Cardiol 2002 90: 1113 7.
25. Piccirillo G, Magnanti M, Matera S, et al. Age and QT variability index during free breathing, controlled breathing and tilt in patient with chronic heart failure and healthy control subjects. Transl Res 2006 148: 72 8.
26. Piccirillo G, Germanò G, Quaglione R, et al. QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy. Clin Sci 2002 102: 363 71.
27. Piccirillo G, Cacciafesta M, Lionetti M, et al. The influence of age, the autonomic nervous system and anxiety on QT interval variability. Clin Sci 2001 101: 429 38.
28. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004 95: 754 63.
29. Buja LM, Roberts WC. Iron in the heart: etiology and clinical significance. Am J Med 1971 51: 209 21.
30. Laurita KR, Chuck ET, Yang T, et al. Optical mapping reveals conduction slowing and impulse block in iron-overload cardiomyopathy. J Lab Clin Med 2003 142: 83 9.
31. Kuryshev YA, Brittenham GM, Fujioka H, et al. Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes. Implication for the arrhythmogenesis of human siderotic heart disease. Circulation 1999 100: 675 83.
32. Schwartz KA, Li Z, Schwartz DE, Cooper TG, Braselton WE. Earliest cardiac toxicity induced by iron overload selectively inhibits electrical conduction. J Appl Physiol 2002 93: 746 51.
33. Piccirillo G, Quaglione R, Fimognari F, et al. Influence of L-arginine and vitamin C on the autonomic nervous system in chronic heart failure secondary to ischemic cardiomyopathy. Am J Cardiol 2004 93: 650 4.
34. Romero Mestre JC, Hernandez A, Agramonte O, Hernandez P. Cardiovascular autonomic dysfunction in sickle cell anemia: a possible risk factor for sudden death? Clin Auton Res 1997 7: 121 5.
35. Livrea MA, Tesoriere L, Pintaudi AM, et al. Oxidative stress and antioxidant status in thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996 88: 3608 14.